AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2024
Dec 4, 2024
35599_dirs_2024-12-04_606ccacc-a98c-4a70-8352-f366bf1f79bf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2024-12-01
Reporting Person: Raykov Rosty (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-12-02 | Common shares | A | 2431 | — | Acquired | 68863 | Direct |
| 2024-12-03 | Common shares | S | 1635 | $6.13 | Disposed | 67228 | Direct |
Footnotes
F1: Represents release of restriction from shares awarded 3-31-2023
F2: Represents shares sold pursuant to a 10b5-1 plan dated December 14, 2023.
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20